Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
CALL
Chevron
CVX
$403B
| $391M | 0.19% |
3,801,300
+414,200
| +12% | +$42.3M |
|
77
CALL
Intel
INTC
$476B
| $379M | 0.18% |
10,036,400
+950,600
| +10% | +$33.7M |
|
78
PUT
AT&T
T
$173B
| $376M | 0.18% |
12,272,686
+2,072,193
| +20% | +$65.5M |
|
79
PUT
Boeing
BA
$169B
| $376M | 0.18% |
2,852,900
+226,800
| +9% | +$29.9M |
|
|
80
PUT
Chevron
CVX
$403B
| $374M | 0.18% |
3,630,400
+275,100
| +8% | +$28.1M |
|
81
CALL
Comcast
CMCSA
$95.3B
| $374M | 0.18% |
11,263,400
+247,200
| +2% | +$8.23M |
|
82
CALL
Johnson & Johnson
JNJ
$651B
| $373M | 0.18% |
3,160,900
-438,200
| -12% | -$53.2M |
|
83
PUT
GE Aerospace
GE
$361B
| $373M | 0.18% |
2,625,178
+1,231,065
| +88% | +$184M |
|
84
CALL
Amgen
AMGN
$238B
| $366M | 0.18% |
2,192,200
-28,900
| -1% | -$4.89M |
|
85
CALL
Biogen
BIIB
$32B
| $365M | 0.18% |
1,164,500
+373,800
| +47% | +$111M |
|
86
CALL
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.93B
| $358M | 0.17% |
2,326,000
+639,025
| +38% | +$91.7M |
|
|
87
PUT
SPDR Gold Trust
GLD
$152B
| $356M | 0.17% |
2,836,500
-834,500
| -23% | -$106M |
|
88
PUT
Morgan Stanley
MS
$336B
| $349M | 0.17% |
10,891,500
-405,100
| -4% | -$12.1M |
|
89
CALL
Baidu
BIDU
$31.6B
| $345M | 0.17% |
1,895,000
+193,000
| +11% | +$33.4M |
|
90
CALL
Bank of America
BAC
$431B
| $342M | 0.17% |
21,830,200
-7,478,000
| -26% | -$111M |
|
91
CALL
United States Oil Fund
USO
$2.24B
| $341M | 0.16% |
3,897,250
+1,564,400
| +67% | +$131M |
|
|
TWTR
92
PUT
DELISTED
Twitter, Inc.
TWTR
| $338M | 0.16% |
14,669,400
+2,173,800
| +17% | +$40.9M |
|
|
MON
93
PUT
DELISTED
Monsanto Co
MON
| $338M | 0.16% |
3,303,500
+484,200
| +17% | +$50.8M |
|
94
Citigroup
C
$221B
| $328M | 0.16% |
6,940,581
-4,000,357
| -37% | -$182M |
|
95
PUT
Pfizer
PFE
$160B
| $327M | 0.16% |
10,191,231
+2,069,002
| +25% | +$69.2M |
|
96
PUT
Merck
MRK
$376B
| $319M | 0.15% |
5,359,891
+3,342,701
| +166% | +$195M |
|
97
PUT
State Street Energy Select Sector SPDR ETF
XLE
$41.7B
| $319M | 0.15% |
9,031,000
+2,771,200
| +44% | +$95M |
|
98
CALL
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
| $318M | 0.15% |
1,125,900
+199,100
| +21% | +$56.1M |
|
99
CALL
Berkshire Hathaway Class B
BRK.B
$1.06T
| $314M | 0.15% |
2,171,200
-273,300
| -11% | -$40M |
|
100
CALL
Coca-Cola
KO
$392B
| $313M | 0.15% |
7,406,200
+1,071,900
| +17% | +$47M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.